SAKAR

Sakar Healthcare Share Price

 
Stock touched all time high

 

Sakar Healthcare live price: ₹589.45. It opened at ₹574 vs previous close ₹572; intraday high/low: ₹598/₹574. The 50 & 200 DMA stand at ₹499.42/₹414.58.

Sakar Healthcare Performance

  • Today's Low
  • ₹574
  • Today's High
  • ₹598
  • 52 Week Low
  • ₹239
  • 52 Week High
  • ₹598
  • Open Price₹574
  • Previous Close₹572
  • Volume142,649
  • 50 DMA₹499.42
  • 100 DMA₹460.03
  • 200 DMA₹414.58

Investment Returns

  • Over 1 Month + 9.44%
  • Over 3 Month + 55.08%
  • Over 6 Month + 64.44%
  • Over 1 Year + 144.06%

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 52
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 1,312
  • P/B Ratio
  • 4.2
  • Average True Range
  • 30.92
  • EPS
  • 11.34
  • Dividend Yield
  • 0
  • MACD Signal
  • 11.52
  • RSI
  • 67.27
  • MFI
  • 68.52

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹589.45
+ 17.1 (2.99%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹531.12
  • 50 Day
  • ₹499.42
  • 100 Day
  • ₹460.03
  • 200 Day
  • ₹414.58

Resistance and Support

587.08 Pivot Speed
  • R3 624.57
  • R2 611.28
  • R1 600.37
  • S1 576.17
  • S2 562.88
  • S3 551.97

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 230.88 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 43% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 96 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-05 Quarterly Results & Others To consider other business matters.
2025-11-07 Quarterly Results & Others To consider other business matters.
2025-07-25 Quarterly Results & Others To consider other business matters.
2025-05-15 Audited results
2025-02-08 Quarterly Results

Sakar Healthcare F&O

Sakar Healthcare Shareholding Pattern

52.86%
13.05%
16.59%
17.5%

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹589 As on 12 April, 2026 | 02:12

The Market Cap of Sakar Healthcare is ₹1311.5 Cr As on 12 April, 2026 | 02:12

The P/E ratio of Sakar Healthcare is 52 As on 12 April, 2026 | 02:12

The PB ratio of Sakar Healthcare is 4.2 As on 12 April, 2026 | 02:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23